Company intelligence / Profile preview

afaf

Charleston, South Carolina, USAafassistancefund.org ↗

Ownership: Private
Development stage: Other

Overview

Afaxys is a leading provider of oral and emergency contraceptives in U.S. clinics, offering a broad portfolio of generic and branded contraceptives as well as adjacent healthcare products such as lidocaine injections. The company focuses on affordable access to sexual and reproductive healthcare for public health providers[1][2][3].

Therapeutic areas: Women's Health
Modalities: Small moleculeHormoneBiologic
Industry: Biotech

Partnerships

Bayer Pharmaceuticals – strategic co-promotion to expand access to IUDs in public/community health centers

Beyond the preview

Go deeper on afaf.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on afaf.

Explore the full profile